지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Background : A number of global clinical guidelines recommend prophylactic anticoagulation on patients admitted to hospitals with coronavirus disease-2019 (COVID-19). However, recommendation on specific dose is lacking, especially for the critically ill. The purpose of this study was to investigate the current usage of prophylactic anticoagulant and its adverse events with bleeding in critically ill COVID-19 patients admitted to nationally-designated wards at a general hospital in Korea. Clinical outcomes with respect to prophylactic anticoagulant dose were also compared.
Methods : We reviewed critically-ill COVID-19 inpatients admitted to a nationally-designated intensive care unit from February 1st, 2020 to May 31st, 2021 and identified the type and dose of prophylactic anticoagulant (AC) administered. Patients were further grouped into standard-dose (standard prophylactic AC) and intermediate-to-therapeutic-dose (higher than standard prophylactic AC) prophylaxis. Data on patients’ baseline characteristics, length of hospitalization, mortality, bleeding, and deep vein thrombosis (DVT) were retrospectively collected and analyzed through bivariate statistical methods. Regression analyses were conducted, with statistically significant patient characteristics as confounding variables, to evaluate the correlation between mortality, bleeding, DVT, length of hospitalization, and prophylactic anticoagulant dose.
Results : Of 93 critically-ill COVID-19 patients, 80 (86.0%) received prophylactic AC. Of those, 60 (75.0%) were administered standard AC and 20 (25.0%), higher than standard AC. Length of hospitalization (36.5 days[n=40] vs. 53.9 days[n=18], p=.012), and mortality (33.3% vs.
10.0%, p=.043) showed statistically significant differences between the two groups. Bleeding also occurred in 16 (26.7%) and 8 (40.0%) patients, respectively, but were not significant (p=.260). Mortality, bleeding, DVT, length of hospitalization and prophylactic anticoagulant dose showed no correlation when analyzed through multivariate logistic and multiple regression.
Conclusion : No significant association was found between the prophylactic anticoagulant dose and the patients’ clinical outcomes or bleeding occurrence. Further research is needed to evaluate prescription patterns of prophylactic anticoagulants for critically-ill COVID-19 patients including other hospitals and the clinical outcomes with thorough monitoring upon use.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
Acute and Critical Care
2023 .05
-
Delayed bleeding after implant surgery in patients taking novel oral anticoagulants: a case report
Journal of dental anesthesia and pain medicine
2017 .01
-
Real-World Bleeding Risk of Anticoagulant and Nonsteroidal Anti-inflammatory Drugs Combotherapy versus Anticoagulant Monotherapy
Gut and Liver
2024 .09
-
내시경 시술 시 고려사항(길잡이): Novel Oral Anticoagulants 복용 중인 환자에서
Korean Journal of Helicobacter Upper Gastrointestinal Research
2016 .01
-
Deep Vein Thrombosis after COVID-19 mRNA Vaccination in a Young Man with Inferior Vena Cava Anomaly Leading to Recurrent Deep Vein Thrombosis
Vascular Specialist International
2022 .12
-
항혈소판 및 항응고제 복용하는 환자의 치과시술 후의 출혈 경향에 대한 후향적 평가
대한통합치과학회지
2020 .01
-
2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: 출혈의 대처와 수술 전후 복약관리
대한내과학회지
2019 .02
-
Postoperative major bleeding risk in patients using oral antiplatelets and/or anticoagulants after laparoscopic gastric cancer surgery
Annals of Surgical Treatment and Research
2023 .02
-
Frequency and risk factors of severe postoperative bleeding after proctological surgery: a retrospective case-control study
Annals of Coloproctology
2022 .10
-
Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
대한뇌졸중학회지
2017 .01
-
Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants
Korean Circulation Journal
2022 .08
-
Prophylactic Antibiotics - What"s New?
대한외과학회 학술대회 초록집
2017 .11
-
A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis
Clinical and Experimental Vaccine Research
2023 .04
-
Post-extraction bleeding in patients on direct oral anticoagulants
대한구강악안면외과학회지
2024 .08
-
Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
Journal of Yeungnam Medical Science
2020 .01
-
Prophylactic Antibiotics in Surgery
대한외과학회 학술대회 초록집
2019 .10
-
Safety and effectiveness of direct oral anticoagulants in fragile patients with venous thromboembolism: a retrospective cohort observational study
Annals of Surgical Treatment and Research
2025 .03
-
Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
대한뇌졸중학회지
2015 .01
-
Feasibility of No Prophylactic Antibiotics Use in Patients Undergoing Total Laparoscopic Distal Gastrectomy for Gastric Carcinoma: a Propensity Score-Matched Case-Control Study
Journal of Gastric Cancer
2019 .01
-
Conservative Management with Anticoagulant/Antiplatelet Versus without Anticoagulant/Antiplatelet for Symptomatic Spontaneous Isolated Dissection of Superior Mesenteric Artery: A Meta-Analysis
대한외과학회 학술대회 초록집
2018 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0